-
Product Insights
NewTranscription Activator BRG1 – Drugs In Development, 2024
The Transcription Activator BRG1 pipeline drugs market research report outlays comprehensive information on the Transcription Activator BRG1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology which include indications of Prostate Cancer, and Solid Tumor. It also reviews key players involved in Transcription Activator BRG1 targeted therapeutics development with respective active and dormant or discontinued projects. Note:...
-
Product Insights
NewCalcium Activated Neutral Protease – Drugs In Development, 2024
The Calcium Activated Neutral Protease pipeline drugs market research report outlays comprehensive information on the Calcium Activated Neutral Protease targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Central Nervous System, Ophthalmology, Musculoskeletal Disorders, and Respiratory which include indications of Traumatic Brain Injury, Alzheimer's Disease, Ophthalmology, Glaucoma, Limb-Girdle Muscular Dystrophy, and Pulmonary Fibrosis. It also reviews key players...
-
Product Insights
NewTissue Type Plasminogen Activator – Drugs In Development, 2024
The Tissue Type Plasminogen Activator pipeline drugs market research report outlays comprehensive information on the Tissue Type Plasminogen Activator targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Infectious Disease, and Respiratory which include indications of Acute Ischemic Stroke, Myocardial Infarction, Coronavirus Disease 2019 (COVID-19), Coronavirus Disease 2019 (COVID-19) Associated Acute Respiratory Distress Syndrome, Bronchitis, and Acute Respiratory...
-
Product Insights
NewPlasminogen Activator Inhibitor 1 – Drugs In Development, 2024
The Plasminogen Activator Inhibitor 1 pipeline drugs market research report outlays comprehensive information on the Plasminogen Activator Inhibitor 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Cardiovascular, Oncology, Gastrointestinal, and Respiratory which include indications of Thrombosis, Arterial Thrombosis, Oncology, Melanoma, Inflammatory Bowel Disease, Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD), Idiopathic Pulmonary Fibrosis, and Bronchiectasis. It also...
-
Product Insights
NewProteinase Activated Receptor 2 – Drugs In Development, 2024
The Proteinase Activated Receptor 2 pipeline drugs market research report outlays comprehensive information on the Proteinase Activated Receptor 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Respiratory, Central Nervous System, Gastrointestinal, and Immunology which include indications of Asthma, Unspecified Respiratory Disorders, Migraine, Unspecified Neurologic Disorders, Inflammatory Bowel Disease, Metabolic Dysfunction-Associated Steatohepatitis (MASH), Psoriasis, and Unspecified Immunological...
-
Product Insights
NewMitogen Activated Protein Kinase 14 – Drugs In Development, 2024
The Mitogen Activated Protein Kinase 14 pipeline drugs market research report outlays comprehensive information on the Mitogen Activated Protein Kinase 14 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Oncology, Central Nervous System, Respiratory, and Immunology which include indications of Pancreatic Cancer, Solid Tumor, Alzheimer's Disease, Dementia, Chronic Obstructive Pulmonary Disease (COPD), Cystic Fibrosis, Inflammation, and Cytokine...
-
Product Insights
NewT Lymphocyte Activation Antigen CD86 – Drugs In Development, 2024
The T Lymphocyte Activation Antigen CD86 pipeline drugs market research report outlays comprehensive information on the T Lymphocyte Activation Antigen CD86 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Immunology, Infectious Disease, Oncology, and Central Nervous System which include indications of Rheumatoid Arthritis, Graft Versus Host Disease (GVHD), Infectious Disease, Coronavirus Disease 2019 (COVID-19), Oncology, Melanoma, Alzheimer's...
-
Product Insights
NewReceptor Activity Modifying Protein 1 – Drugs In Development, 2024
The Receptor Activity Modifying Protein 1 pipeline drugs market research report outlays comprehensive information on the Receptor Activity Modifying Protein 1 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, and Gastrointestinal which include indications of Type 2 Diabetes, Obesity, and Metabolic Dysfunction-Associated Steatohepatitis (MASH). It also reviews key players involved in Receptor Activity Modifying Protein...
-
Product Insights
NewReceptor Activity Modifying Protein 2 – Drugs In Development, 2024
The Receptor Activity Modifying Protein 2 pipeline drugs market research report outlays comprehensive information on the Receptor Activity Modifying Protein 2 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, and Gastrointestinal which include indications of Type 2 Diabetes, Obesity, and Metabolic Dysfunction-Associated Steatohepatitis (MASH). It also reviews key players involved in Receptor Activity Modifying Protein...
-
Product Insights
NewReceptor Activity Modifying Protein 3 – Drugs In Development, 2024
The Receptor Activity Modifying Protein 3 pipeline drugs market research report outlays comprehensive information on the Receptor Activity Modifying Protein 3 targeted therapeutics, complete with analysis by indications, stage of development, mechanism of action (MoA), route of administration (RoA) and molecule type. The report also covers products from therapy areas such as Metabolic Disorders, and Gastrointestinal which include indications of Type 2 Diabetes, Obesity, and Metabolic Dysfunction-Associated Steatohepatitis (MASH). It also reviews key players involved in Receptor Activity Modifying Protein...